Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification
Real-time Elastography for Non-invasive Assessment of Liver Fibrosis and Fat Quantification Techniques for Assessment of Fatty Change in Chronic Liver Disease
1 other identifier
interventional
180
1 country
1
Brief Summary
Liver stiffness is a marker for scarring of the liver, which occurs after damage from various liver conditions. Scarring prevents normal liver function and can lead to liver failure. Fatty liver is a common cause of liver damage and can contribute to scarring. Currently, liver biopsy serves as the 'gold standard' for assessing the degree of liver scarring and fatty infiltration, guiding treatment decisions. However, liver biopsy poses a significant risk of death and unpleasant side effects, including internal bleeding and pain. Moreover, due to the small sample of liver tissue obtained during the biopsy, the results can be misleading and may not provide an accurate overview of the liver's health. Therefore, there is an unmet need for a non-invasive method of measuring liver stiffness and fat content. Ultrasound-based methods utilize various properties of ultrasound waves to assess liver stiffness and fat levels. This study aims to recruit 100-120 patients with chronic liver disease. The investigators will assess liver stiffness and fat levels during patients' hospital visits for routine scans, biopsies, or clinic appointments. The resulting measurements of liver stiffness and fat obtained through ultrasound-based methods will be compared to patients' routine liver biopsies, routine FibroScan results (another non-invasive method routinely used in clinical care to assess patients' liver stiffness), and other non-invasive severity scores (calculated from results obtained from patients' routine blood tests, providing an overview of the extent of liver damage).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2023
CompletedFirst Submitted
Initial submission to the registry
September 14, 2023
CompletedFirst Posted
Study publicly available on registry
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 2, 2025
CompletedNovember 1, 2023
October 1, 2023
2 years
September 14, 2023
October 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Diagnostic accuracy of liver elastography compared to histological staging
Comparison of ultrasound elastography measures and biopsy based fibrosis scores
3 years
Diagnostic accuracy of liver fat quantification compared to histological assessment
Comparison of ultrasound fat quantification measures and biopsy based fat percentages
3 years
Study Arms (1)
Liver Biopsy Cohort
EXPERIMENTALInterventions
Correlation of ultrasound-based elastography and fat quantification on liver biopsy
Eligibility Criteria
You may qualify if:
- \>=18 years old
- Male or Female
- Suspected chronic liver disease based on clinical history, serum biochemistry, prior imaging or prior liver biopsy
- Willing and able to provide written informed consent.
You may not qualify if:
- Liver transplantation within the last six months
- Suspected or known acute liver disease
- Focal liver lesion(s)
- Age \<18 years old
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Hospital NHS Trustlead
- Samsung Medisoncollaborator
Study Sites (1)
Nuran Seneviratne
London, SE13 5FX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2023
First Posted
November 1, 2023
Study Start
January 2, 2023
Primary Completion
January 2, 2025
Study Completion
July 2, 2025
Last Updated
November 1, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share